Allscripts-Misys Healthcare Solutions, which has a major presence in the Triangle, and its rival Eclipsys are combining in a $1.35 billion all-stock deal, the companies announced early Wednesday.

CHICAGO – Officials at the newly formed AllscriptsMisys Healthcare Solutions want to shake up the healthcare industry. That kind of thinking comes from being one of the biggest kids on the block – and ...

The official word from executives at Misys and Allscripts after the two companies announced a proposed merger in late March was resoundingly positive. Misys CEO Mike Lawrie called Allscripts the ...

Jan 9 (Reuters) - Shares of Allscripts-Misys Healthcare Solutions Inc were up more than 7 percent, a day after the healthcare software firm posted its first quarterly results post merger. Allscripts ...

The offer is being made by the selling stockholders only by means of a prospectus supplement and accompanying prospectus, forming an effective part of the registration statement. Before investing, you ...

Misys Healthcare is being split-off from its parent and is acquiring 54% of Allscripts. The deal could be a big win for open source. Or it might not be. It might be because Misys Healthcare fulfilled ...

Allscripts-Misys outperforms Street expectations for bookings in its third quarter, a key indicator of a pickup in the adoption of electronic records by the health-care sector. Earnings per share of ...

The complex field of health-care information may soon be a little more streamlined. On Tuesday, Chicago-based electronic medical records provider Allscripts announced it has agreed to merge with ...

"Allscripts, representing our many clients, was pleased to be a participant in the Agency's development of the final rule, and believes that clear guidance can only help accelerate the use of ...

Allscripts-Misys Healthcare Solutions has signed two more contracts to provide healthcare IT solutions for healthcare providers and affiliated physicians in four states. The Chicago-based company has ...

LONDON/NEW YORK, June 9 (Reuters) - U.S. healthcare IT company Allscripts plans to buy rival Eclipsys in a $1.3 billion all-stock deal to capitalize on a huge influx of U.S. government funding for ...